Evidence map›Paper›PMID 31620123›Full record

ArticleFrontiers in immunology2019

C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions.

Rachel V Jimenez, Valeriya Kuznetsova, Ashley N Connelly, Zdenek Hel, Alexander J Szalai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Role of C-Reactive Protein in Kidney Diseases.Kidney diseases (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rachel V JimenezDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Valeriya KuznetsovaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Ashley N ConnellyDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Zdenek HelDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Alexander J SzalaiDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
University of Alabama at Birmingham · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
C-reactive protein in acute kidney injuryR01DK099092 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SZALAI, ALEXANDER J · 2014 to 2017
$1.3M
C-reactive protein mediated signals in renal injury and repairF31DK112646 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JIMENEZ, RACHEL V · 2017 to 2019
$106k
NIAID NIH HHS P30AI27767NIAMS NIH HHS P30 AR048311NIDDK NIH HHS F31 DK112646NIDDK NIH HHS R01 DK099092
6 · The paper itself

Abstract

Previously we established that human C-reactive protein (CRP) exacerbates mouse acute kidney injury and that the effect was associated with heightened renal accumulation of myeloid derived cells with suppressor functions (MDSC). Herein we provide direct evidence that CRP modulates the development and suppressive actions of MDSCs

Indexed as

AnimalsC-Reactive ProteinHumansImmunity, InnateInflammationMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsC-Reactive Proteinacute phase responsecancerinflammationinnate immunitymyelopoiesis

Identifiers

PMID31620123
PMCPMC6759522
OpenAlexW2970605490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.